Purpose/Objectives: To assess fear of progression (FoP) in outpatients with chronic myeloid leukemia (CML) on oral tyrosine kinase inhibitors (TKIs). Design: Prospective and descriptive. Setting: A university-based outpatient cancer clinic in Wuerzburg, Germany. Sample: 37 outpatients with CML on...